Effectiveness and safety analysis of Danggui Shaoyao Powder for the treatment of non-alcoholic fatty liver disease: study protocol for a randomized, double-blind, placebo-controlled clinical trial

BACKGROUND: The incidence of non-alcoholic fatty liver disease (NAFLD) has been on the rise in recent years, and there are no effective drugs to treat NAFLD; therefore, effective prevention and treatment of NAFLD have become a new challenge. Danggui Shaoyao Powder (DGSY) is a classic prescription co...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Qian, An, Ziming, Xin, Xin, Sun, Qinmei, Gao, Siting, Lv, Sheng, Xu, Xiao, Yang, Shuohui, Lu, Fang, Yuan, Jie, Zhao, Yu, Hu, Yiyang, Liu, Ping, Feng, Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114303/
https://www.ncbi.nlm.nih.gov/pubmed/37076843
http://dx.doi.org/10.1186/s12906-023-03948-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114303/
https://www.ncbi.nlm.nih.gov/pubmed/37076843
http://dx.doi.org/10.1186/s12906-023-03948-3

Ejemplares similares